VaxCorps forms network of clinical research centers
The trials have included vaccines for both seasonal and pandemic influenza as well as biodefense and infectious illnesses. VaxCorps clinical sites have conducted more than 500 successful Phase I-IV clinical trials for vaccines.
VaxCorps has committed itself and its members to the best standards for subject safety, research excellence, data integrity, outstanding subject retention, rapid study startup and enrollment. Its members -- including Miami Research Associates (MRA), Piedmont Medical Group (PMG) and Benchmark Research -- are already renowned leaders in the global vaccine industry.
MRA, PMG and Benchmark were recently chosen by their peers and clients as finalists in the 2015 World Vaccine Congress’ Industry Excellence Awards.